Promote Sponsor
verified SJR 5,446 · Q1 • database Scopus / SJR & Web of Science indexed
The Lancet Infectious Diseases
United Kingdom · Elsevier Ltd
workspace_premium Q1 — Infectious Diseases lock_open Open Access Unclaimed

The Lancet Infectious Diseases

The Lancet Infectious Diseases is a journal indexed in SJR in Infectious Diseases with an H index of 304. It has an SJR impact factor of 5,446 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 5,446.

The Lancet Infectious Diseases focuses its scope in these topics and keywords: vaccine, treatment, disease, health, malaria, virus, south, hiv, vaccines, systematic, ...

ISSN: 1473-3099
Editorial: Elsevier Ltd
Category: Infectious Diseases
Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD
schedule Datos CoP · solo campos en BD
SJR Impact Factor trending_up
5,446 Q1
H-index 304
Tasa de Aceptación pie_chart
18% Selectiva
Fuente Acceptance_Rate
Tiempo a publicación hourglass_top
NPD
Campo Sin dato
Coste de Publicación (APC) payments
NPD Open Access
Ruta Non-OA 0 €

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

5,446

H-index

304

Docs (year)

517

Docs 3y

1504

Total refs

8147

Cites 3y

11867

Citable 3y

657

Cites/Doc 2y

8.68

Ref/Doc

15.76

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Consumers need to change attitude to antibiotic use

View more

Wish you weren't here

View more

Epstein-Barr virus further linked to Hodgkin's lymphoma

View more

Emergency diagnosis and treatment of adult meningitis

View more

Efficacy and effectiveness of ten-valent versus 13-valent pneumococcal conjugate vaccines -Authors' reply

View more

Efficacy and effectiveness of ten-valent versus 13-valent pneumococcal conjugate vaccines

View more

Early prevention of pertussis is key -Author's reply

View more

Early prevention of pertussis is key

View more

Development of vaccines against influenza H5

View more

Development and evaluation of influenza pandemic vaccines

View more

De Libris

View more

Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens

View more
SHOW MORE ARTICLES

Controversial antibiotic use for crops approved in Florida

View more

2017 ECIL 7 vaccine guidelines

View more

Clinton pledges cheap antiretrovirals

View more

Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso

View more

Challenges in tracking global malaria spending

View more

Challenges and opportunities for the management of infectious diseases in Europes' prisons: evidence-based guidance

View more

Avascular necrosis of femoral heads in a man with HIV infection

View more

Antimicrobial therapy to prevent or treat oral mucositis

View more

Amoebae hide a giant

View more

All for one and one for all: the true potential of whole-genome sequencing

View more

African tick bite fever

View more

Acute lung injury and other serious complications of Plasmodium vivax malaria

View more

FAQS